The intervention group have been treated with risperidone(maximum dose 2 mg) is also treated with placebo. The duration of intervention is 12 weeks.
Sponsors
Vice Chancellor for Research of Mashhad University of Medical Sciences
Conditions
Autism Spectrum Disorders.
Pervasive developmental disorders
Unknown Phase
The efficacy of augmentation Flavonoid Quercetin to risperidon in treatment of autism spectrum disorders
Active, not recruitingIRCT2017013132326N1
Start: 2017-03-05Target: 70Updated: 2018-02-22
The efficacy of augmentation Donepezil to risperidon in treatment of autism spectrum disorders
Active, not recruitingIRCT2017041333406N1
Start: 2017-07-06Target: 66Updated: 2018-02-22